Which Magnificent 7 Stock Had The Best Year In 2025?
While Nvidia had another strong year, it was not the best performing Magnificent 7 stock in 2025.
Stocks And Precious Charts - VIX Is Mesmerized
The dollar took a nose dive, but retains its seat of power.
An Alzheimer’s Drug Could Supercharge This High-Risk Stock. Is It Worth A Buy Here?
vTv Therapeutics is a $156 million biopharma focused on small molecule drugs for Alzheimer’s, diabetes, and inflammatory disorders, all in clinical trials.
Short Squeezes Are Brewing
When someone buys thousands of call contracts, market makers have to hedge by purchasing stock. That buying pressure forces shorts to cover, creating a feedback loop that can send prices soaring.
Market Talk - Monday, Jan. 5
The oil markets had a mixed day today.